1-2 of 2
Mark F. Kozloff
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of Venetoclax (VEN) in Combination with Bendamustine (B) Plus Rituximab (R) or Obinutuzumab (G) in Patients (pts) with Previously Untreated Chronic Lymphocytic Leukemia (CLL): Results from a Phase Ib Study (GO28440)

Stephan Stilgenbauer, Franck Morschhauser, Clemens-Martin Wendtner, Guillaume Cartron, Michael Hallek, Barbara Eichhorst, Mark F. Kozloff, Thomas Giever, Gerard Lozanski, MD, Yanwen Jiang, Huang Huang, Daniela Soriano Pignataro, William Schary, Kathryn Humphrey, Mehrdad Mobasher, MD MPH, Gilles Salles, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1859.
https://doi.org/10.1182/blood-2018-99-118362
Published: 2018
Journal Articles

Demographics By Age Group (AG) and Line of Therapy (LOT) in Chronic Lymphocytic Leukemia (CLL) Patients (Pts) Treated in US Practices from the Connect ® CLL Registry

Jeff P. Sharman, MD, Anthony Mato, Neil E. Kay, MD, Thomas J. Kipps, MD, Nicole Lamanna, Mark Weiss, MD, Chadi Nabhan, Ian Flinn, David L. Grinblatt, Mark F. Kozloff, Charles M. Farber, Kirsten Sullivan, Thomas Street, Arlene S. Swern, PhD, Christopher R. Flowers, MD
Journal: Blood
Blood (2014) 124 (21): 3338.
https://doi.org/10.1182/blood.V124.21.3338.3338
Published: 2014